Form D · Pharmaceuticals
LigoCyte Pharmaceuticals Inc
Bozeman, MT · CIK 0001400794
Offering snapshot reported Jun 28, 2012 · SEC filing
- Reported sold
- $2M Offering amount: $22.1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 21, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 28, 2012 | Initial | $2,000,000 | No comparison | 7 | SEC filing |
| Jun 21, 2011 | Initial | $5,500,000 | No comparison | 11 | SEC filing |
| May 28, 2010 | Amendment | $6,572,305 | $72,305vs Apr 22, 2010 | 15 | SEC filing |
| Apr 22, 2010 | Initial | $6,500,000 | No comparison | 11 | SEC filing |
| Aug 14, 2009 | Amendment | $29,490,335 | No comparison | 23 | SEC filing |
| Apr 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-180453
Source: Form D, filed Jun 28, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ben Auspitz | Director |
| Donald Beeman | Director, Executive |
| C. Boyd Clarke | Director, Executive |
| J. Donald De Bethizy | Director |
| J. Donald De Bethizy, Ph.D. | Director |
| Markus Goebel | Director |
| Markus Goebel, M.D., Ph.D. | Director |
| Robert Goodwin | Executive |
| Rob Goodwin | Executive |
| Hironori Hozoji | Director |
| George Kemble | Director |
| George Kemble, Ph.D. | Director |
| Larry Mikkola | Executive |
| Ivor Royston | Director |
| Ivor Royston, M.D. | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2155 Analysis Drive
Bozeman, MT, 59718
Bozeman, MT, 59718